HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $830,945 | -96.6% | 23,037 | -96.4% | 0.00% | -97.7% |
Q1 2023 | $24,205,395 | -31.3% | 633,815 | +2.4% | 0.04% | -36.8% |
Q4 2022 | $35,231,228 | +26.2% | 619,178 | -12.3% | 0.07% | +19.3% |
Q3 2022 | $27,927,000 | -15.0% | 706,278 | -5.4% | 0.06% | +83.9% |
Q2 2022 | $32,855,000 | +34.6% | 746,689 | +22.0% | 0.03% | +72.2% |
Q1 2022 | $24,404,000 | +3.5% | 611,960 | +4.4% | 0.02% | +12.5% |
Q4 2021 | $23,575,000 | +3.3% | 586,274 | +4.5% | 0.02% | -11.1% |
Q3 2021 | $22,826,000 | +99.6% | 561,113 | +122.9% | 0.02% | +80.0% |
Q2 2021 | $11,434,000 | +708.6% | 251,786 | +642.6% | 0.01% | +900.0% |
Q1 2021 | $1,414,000 | -63.8% | 33,906 | -62.9% | 0.00% | -75.0% |
Q4 2020 | $3,905,000 | +92.7% | 91,428 | +18.6% | 0.00% | +100.0% |
Q3 2020 | $2,026,000 | -39.9% | 77,101 | -38.7% | 0.00% | -50.0% |
Q2 2020 | $3,372,000 | +804.0% | 125,785 | +506.4% | 0.00% | +300.0% |
Q1 2020 | $373,000 | -88.3% | 20,742 | -88.4% | 0.00% | -66.7% |
Q4 2019 | $3,182,000 | +66.9% | 179,452 | +61.7% | 0.00% | +50.0% |
Q2 2019 | $1,906,000 | +7.2% | 110,968 | +0.5% | 0.00% | 0.0% |
Q1 2019 | $1,778,000 | +385.8% | 110,410 | +447.7% | 0.00% | – |
Q3 2018 | $366,000 | -62.8% | 20,158 | -65.4% | 0.00% | -100.0% |
Q2 2018 | $983,000 | -13.9% | 58,295 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $1,142,000 | -12.0% | 58,295 | -8.9% | 0.00% | 0.0% |
Q4 2017 | $1,297,000 | -2.2% | 63,991 | -16.1% | 0.00% | 0.0% |
Q3 2017 | $1,326,000 | +48.0% | 76,309 | +9.9% | 0.00% | 0.0% |
Q2 2017 | $896,000 | -51.9% | 69,421 | -51.6% | 0.00% | -50.0% |
Q1 2017 | $1,862,000 | +39.6% | 143,521 | +6.3% | 0.00% | +100.0% |
Q4 2016 | $1,334,000 | -51.2% | 134,982 | -40.8% | 0.00% | -66.7% |
Q3 2016 | $2,735,000 | +46.8% | 227,920 | +5.6% | 0.00% | +50.0% |
Q2 2016 | $1,863,000 | +86.7% | 215,889 | +104.9% | 0.00% | +100.0% |
Q1 2016 | $998,000 | -44.9% | 105,369 | +1.3% | 0.00% | -50.0% |
Q4 2015 | $1,810,000 | +19.9% | 104,045 | -7.4% | 0.00% | 0.0% |
Q3 2015 | $1,510,000 | -35.7% | 112,380 | +8.0% | 0.00% | -33.3% |
Q2 2015 | $2,349,000 | +86.4% | 104,045 | +17.9% | 0.00% | +200.0% |
Q1 2015 | $1,260,000 | +69.1% | 88,245 | +14.2% | 0.00% | 0.0% |
Q4 2014 | $745,000 | -41.6% | 77,245 | -44.9% | 0.00% | -50.0% |
Q3 2014 | $1,276,000 | +10.2% | 140,245 | +19.6% | 0.00% | +100.0% |
Q2 2014 | $1,158,000 | -13.4% | 117,245 | +11.4% | 0.00% | -50.0% |
Q1 2014 | $1,337,000 | -11.0% | 105,245 | +5.0% | 0.00% | 0.0% |
Q4 2013 | $1,503,000 | +18.2% | 100,245 | -13.0% | 0.00% | 0.0% |
Q3 2013 | $1,272,000 | +96.9% | 115,245 | +41.8% | 0.00% | +100.0% |
Q2 2013 | $646,000 | – | 81,245 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |